Pharmaseq Inc Monmouth Junction, NJ - 08852

Pharmaseq Inc is categorized under Diagnostic Substances in Monmouth Junction, NJ and active since 1996.

Pharmaseq Inc was established in 1996, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 4242101 by the NAICS.

If you are seeking more information, feel free to contact Wlodek Mandecki, President at the company’s single location by writing to 11 Deerpark Drive # 104, Monmouth Junction, New Jersey NJ 08852 or by phoning (732) 355-0100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pharmaseq Inc
Contact Person: Wlodek Mandecki, President
Address: 11 Deerpark Drive # 104, Monmouth Junction, New Jersey 08852
Phone Number: (732) 355-0100
Website Address: pharmaseq.com
Annual Revenue (USD): $20.000.000 to $49.9999.999
Founded: 1996
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Diagnostic Substances
SIC Code: 2835
NAICS Code: 4242101
Share This Business:

Pharmaseq Inc was started in 1996 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.

Feel free to contact Wlodek Mandecki, President for inquiries that concern Pharmaseq Inc by calling the company number (732) 355-0100, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaseq Inc can be found at the coordinates 40.376031,-74.58501 as well as the street address 11 Deerpark Drive # 104 in Monmouth Junction, New Jersey 08852.

For its online presence, you may visit Pharmaseq Inc’s website at pharmaseq.com and engage with its social media outlets through on Twitter and on Facebook.